The Value of Multi-modal Multi-indicator Multi-view Stereoscopic Assessment System (MMM-SAS) Based on Breast Ultrasound for Breast Cancer Risk Prediction

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000041370

Enrollment

Unknown

Registered

2020-12-24

Start date

2021-01-01

Completion date

Unknown

Last updated

2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Gold Standard:Pathological diagnosis

Index test:Multi-parameter&#32

breast&#32

ultrasound

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: (1) BI-RADS4 nodules were diagnosed by routine ultrasound examination, (2) informed of this study, and signed an informed consent form. Voluntary shear wave elastography examination; (3) agreed and combined with puncture biopsy, rotary biopsy, or surgical treatment, and finally obtained the pathological diagnosis.

Exclusion criteria

Exclusion criteria: (1) pregnancy or lactation; (2) implants in the breast; (3) history of surgery on the affected side; (4) history of malignant tumor and other cachexia.

Design outcomes

Primary

Measure	Time frame
Emax;Emin;Eratio;Emean;RI;Vmax;SEN, SPE, ACC, AUC of ROC;	—

Countries

China

Contacts

Public ContactJing Pei

The First Affiliated Hospital of Anhui Medical University

peijing@ahmu.edu.cn+86 13966668272

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026